Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianxin Lin

Showing results (91-100 of 237) with videos related to

Pageof 24
Sort By:
Biochimica Et Biophysica Acta|May 22, 2013
linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancerWang He, Qingqing Cai, Fenyong Sun, et al.
Cancer Treatment Reviews|January 1, 2013
Systematic review and meta-analysis of comparative studies reporting early outcomes after robot-assisted radical cystectomy versus open radical cystectomyKaiwen Li, Tianxin Lin, Xinxiang Fan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2017
A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder CancerShaoxu Wu, Junjiong Zheng, Yong Li, et al.
Journal of Endourology|November 7, 2018
A Novel Semirigid Ureterorenoscope with Vacuum Suctioning System for Management of Single Proximal Ureteral and Renal Pelvic Stones: An Initial ExperienceKaiwen Li, Zhijian Liao, Tianxin Lin, et al.
Cancer Medicine|April 16, 2023
Singe intraoperative instillation of chemotherapy during radical cystectomy for bladder cancer: Oncological outcome and survival predictorsJingtian Yang, Kaiwen Li, Yishan Zhang, et al.
Medcomm|July 15, 2025
Intravesical Disitamab Vedotin (RC48) for HER2-Expressing High-Risk Non-Muscle-Invasive Bladder Cancer: A Single-Arm, Dose-Escalation Phase I Trial StudyXu Chen, Ming Huang, Zehua Chen, et al.
World Journal of Urology|July 15, 2019
Microlocalization and clinical significance of stabilin-1<sup>+</sup> macrophages in treatment-naïve patients with urothelial carcinoma of the bladderBo Wang, Hao Huang, Meihua Yang, et al.
Bladder (San Francisco, Calif.)|September 23, 2024
A narrative review of advances in the management of urothelial cancer: Diagnostics and treatmentsShaoxu Wu, Shengwei Xiong, Juan Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 20, 2023
ETV4 Mediated Tumor-Associated Neutrophil Infiltration Facilitates Lymphangiogenesis and Lymphatic Metastasis of Bladder CancerQiang Zhang, Sen Liu, Hongjin Wang, et al.
Cancer Science|December 15, 2018
Programmed death ligand-1 is associated with tumor infiltrating lymphocytes and poorer survival in urothelial cell carcinoma of the bladderBo Wang, Wenwei Pan, Meihua Yang, et al.
Pageof 24

Showing results (91-100 of 237) with videos related to

Sort By:
Pageof 24
Biochimica Et Biophysica Acta|May 22, 2013
linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancerWang He, Qingqing Cai, Fenyong Sun, et al.
Cancer Treatment Reviews|January 1, 2013
Systematic review and meta-analysis of comparative studies reporting early outcomes after robot-assisted radical cystectomy versus open radical cystectomyKaiwen Li, Tianxin Lin, Xinxiang Fan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2017
A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder CancerShaoxu Wu, Junjiong Zheng, Yong Li, et al.
Journal of Endourology|November 7, 2018
A Novel Semirigid Ureterorenoscope with Vacuum Suctioning System for Management of Single Proximal Ureteral and Renal Pelvic Stones: An Initial ExperienceKaiwen Li, Zhijian Liao, Tianxin Lin, et al.
Cancer Medicine|April 16, 2023
Singe intraoperative instillation of chemotherapy during radical cystectomy for bladder cancer: Oncological outcome and survival predictorsJingtian Yang, Kaiwen Li, Yishan Zhang, et al.
Medcomm|July 15, 2025
Intravesical Disitamab Vedotin (RC48) for HER2-Expressing High-Risk Non-Muscle-Invasive Bladder Cancer: A Single-Arm, Dose-Escalation Phase I Trial StudyXu Chen, Ming Huang, Zehua Chen, et al.
World Journal of Urology|July 15, 2019
Microlocalization and clinical significance of stabilin-1<sup>+</sup> macrophages in treatment-naïve patients with urothelial carcinoma of the bladderBo Wang, Hao Huang, Meihua Yang, et al.
Bladder (San Francisco, Calif.)|September 23, 2024
A narrative review of advances in the management of urothelial cancer: Diagnostics and treatmentsShaoxu Wu, Shengwei Xiong, Juan Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 20, 2023
ETV4 Mediated Tumor-Associated Neutrophil Infiltration Facilitates Lymphangiogenesis and Lymphatic Metastasis of Bladder CancerQiang Zhang, Sen Liu, Hongjin Wang, et al.
Cancer Science|December 15, 2018
Programmed death ligand-1 is associated with tumor infiltrating lymphocytes and poorer survival in urothelial cell carcinoma of the bladderBo Wang, Wenwei Pan, Meihua Yang, et al.
Pageof 24